Biosynthesis Butyl acetate

As discussed earlier, the avermectin polyketide backbone is derived from seven acetate and five propionate extender units added to an a branched-chain fatty acid starter, which is either (S( I )-a-mcthylbutyric acid or isobutyric acid. The C25 position of naturally occurring avermectins has two possible substituents a. sec-butyl residue derived from the incorporation of S(+)-a-methy lbutyry 1-CoA ( a avermectins), or an isopropyl residue derived from the incorporation of isobutyiyl-CoA ( b avermectins). These a branched-chain fatty acids, which act as starter units in the biosynthesis of the polyketide ring, are derived from the a branched-chain amino acids isoleucine and valine through a branched-chain amino acid transaminase reaction followed by a branched-chain a-keto acid dehydrogenase (BCDH) reaction (Fig. 5) [23]. 

Biosynthesis of the polycychc diterpene intricarene (144) may occur from the natural product bipinnatin J (141) through transannular [5 - - 2] cycloaddition reaction. Based upon this proposed biosynthetic route, Tang et al. examined a synthesis of 144 [45]. Synthetic 141 was treated with VO(acac)2 and fert-butyl hydroperoxide, followed by acetic anhydride to give acetoxypyranone 142, which was subsequently heated in acetonitrile in the presence of DBU to give intricarene (144) (Scheme 7.32). 

In 1985, O Malley et al. published the total syntheses of rac-averufin (103) and rac-nidurufin (104) (65). These are both early precursors of the aflatoxins in their biosynthesis. Nidurufin (104) is the direct successor of averufin (103) and the direct precursor of versiconal hemiacetal acetate (12, see Scheme 2.1). Nidurufin (104) and averufin (103) are accessible by the same synthesis route only the two last steps differ firom each other (see Scheme 2.17). The first reaction was a double Diels-Alder reaction with dichloro-p-benzoquinone (97) and two equivalents of diene 98. Then, three of the four alcohol functions were selectively MOM-protected (—> 99). The remaining alcohol was converted into the allyl ether and then subjected to a reductive Claisen rearrangement, followed by MOM-protection of the redundant alcohol ( 100). By addition/elimination of PhSeCl, 101 was formed. Deprotonation of t-butyl 3-oxobutanoate, followed by reaction with 101 yielded the pivotal intermediate 102. This could be converted into rac-averufin (103) by deprotection of the alcohols and decarboxylation at the side chain. The last step was a p-TsOH-catalyzed cyclization to give 103. By treating 102 with /m-CPBA, the double bond is epoxidized. rac-Nidurufin (104) was then formed by cyclization of this epoxide under acidic conditions. 

---